Fast reduction of peripheral blood endothelial progenitor cells in healthy humans exposed to acute systemic hypoxia

Journal of Physiology

Volumn 590, Issue 3, 2012, Pages 519-532

  Colombo, Elena ^a   Marconi, Claudio ^b   Taddeo, Adriano ^a   Cappelletti, Monica ^a   Villa, Maria Luisa ^a   Marzorati, Mauro ^b   Porcelli, Simone ^b,c   Vezzoli, Alessandra ^b   Della Bella, Silvia ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b CNR   (Italy)

^c Faculty of Architecture and Industrial Design   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CD133 ANTIGEN; CD34 ANTIGEN; CD45 ANTIGEN; CELL MARKER; CHEMOKINE RECEPTOR CXCR4; STROMAL CELL DERIVED FACTOR 1; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 2;

ADULT; AMBIENT AIR; APOPTOSIS; ARTICLE; CELL FUNCTION; CELL HOMING; CELL KINETICS; CELL MIGRATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ENDOTHELIAL PROGENITOR CELL; FLOW CYTOMETRY; HOMEOSTASIS; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; HYPOXIA; LUNG GAS EXCHANGE; MALE; NORMAL HUMAN; OXIDATIVE STRESS; PERIPHERAL BLOOD STEM CELL; PHENOTYPIC VARIATION; PHYSIOLOGICAL PROCESS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; REDUCTION KINETICS;

ADULT; ANOXIA; APOPTOSIS; CELL COUNT; CHEMOKINE CXCL12; ENDOTHELIUM, VASCULAR; HUMANS; MALE; PROTEIN CARBONYLATION; RECEPTORS, CXCR4; STEM CELLS; THIOBARBITURIC ACID REACTIVE SUBSTANCES; VASCULAR ENDOTHELIAL GROWTH FACTOR A; YOUNG ADULT;

EID: 84856316977     PISSN: 00223751     EISSN: 14697793     Source Type: Journal    
DOI: 10.1113/jphysiol.2011.223032     Document Type: Article

References (55)

1. Aicher A, Zeiher AM & Dimmeler S (2005). Mobilizing endothelial progenitor cells. Hypertension 45, 321-325.
2. Asahara T & Kawamoto A (2004). Endothelial progenitor cells for postnatal vasculogenesis. Am J Physiol Cell Physiol 287, C572-C579.
3. Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T et al (1997). Isolation of putative progenitor endothelial cells for angiogenesis. Science 275, 964-967.
4. Bahlmann FH, De Groot K, Spandau JM, Landry AL, Hertel B, Duckert T et al (2004). Erythropoietin regulates endothelial progenitor cells. Blood 103, 921-926.
5. Bogoslovsky T, Spatz M, Chaudhry A, Maric D, Luby M, Frank J & Warach S (2011). Stromal-derived factor-1 correlates with circulating endothelial progenitor cells and with acute lesion volume in stroke patients. Stroke 42, 618-625.
6. Ceradini DJ & Gurtner GC (2005). Homing to hypoxia: HIF-1 as a mediator of progenitor cell recruitment to injured tissue. Trends Cardiovasc Med 15, 57-63.
7. Ceradini DJ, Kulkarni AR, Callaghan MJ, Tepper OM, Bastidas N, Kleinman ME et al (2004). Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nat Med 10, 858-864.
8. Chacko SM, Ahmed S, Selvendiran K, Kuppusamy ML, Khan M & Kuppusamy P (2010). Hypoxic preconditioning induces the expression of prosurvival and proangiogenic markers in mesenchymal stem cells. Am J Physiol Cell Physiol 299, C1562-C1570.
9. Ciulla M, Cortiana M, Silvestris I, Matteucci E, Ridolfi E, Giofrè F et al (2007). Effects of simulated altitude (normobaric hypoxia) on cardiorespiratory parameters and circulating endothelial precursors in healthy subjects. Respir Res 8, 58.
10. Cobellis G, Botti C, Taddeo A, Silvestroni A, Lillo S, Da Ponte A et al (2010). Successful bone marrow transplantation reveals the lack of endothelial progenitor cells mobilization in a patient with critical limb ischemia: a case report. Transplant Proc 42, 2816-2820.
11. Fadini GP, Sartore S, Agostini C & Avogaro A (2007). Significance of endothelial progenitor cells in subjects with diabetes. Diabetes Care 30, 1305-1313.
12. Fadini GP, Schiavon M, Cantini M, Baesso I, Facco M, Miorin M et al (2006). Circulating progenitor cells are reduced in patients with severe lung disease. Stem Cells 24, 1806-1813.
13. Feldser D, Agani F, Iyer NV, Pak B, Ferreira G & Semenza GL (1999). Reciprocal positive regulation of hypoxia-inducible factor 1α and insulin-like growth factor 2. Cancer Res 59, 3915-3918.
14. Fleissner F & Thum T (2010). Critical role of the nitric oxide/reactive oxygen species balance in endothelial progenitor dysfunction. Antioxid Redox Signal 15, 933-948.
15. Gelfi C, De Palma S, Ripamonti M, Eberini I, Wait R, Bajracharya A et al (2004). New aspects of altitude adaptation in Tibetans: a proteomic approach. FASEB J 18, 612-614.
16. Harrison JS, Rameshwar P, Chang V & Bandari P (2002). Oxygen saturation in the bone marrow of healthy volunteers. Blood 99, 394.
17. Hellwig-Burgel T, Rutkowski K, Metzen E, Fandrey J & Jelkmann W (1999). Interleukin-1β and tumor necrosis factor-α stimulate DNA binding of Hypoxia-inducible factor-1. Blood 94, 1561-1567.
18. Hu Y, Davison F, Zhang Z & Xu Q (2003). Endothelial replacement and angiogenesis in arteriosclerotic lesions of allografts are contributed by circulating progenitor cells. Circulation 108, 3122-3127.
19. Ii M, Nishimura H, Iwakura A, Wecker A, Eaton E, Asahara T & Losordo DW (2005). Endothelial progenitor cells are rapidly recruited to myocardium and mediate protective effect of ischemic preconditioning via 'imported' nitric oxide synthase activity. Circulation 111, 1114-1120.
20. + hemangiocytes. Nat Med 12, 557-567.
21. Jin Y, An X, Ye Z, Cully B, Wu J & Li J (2009). RGS5, a hypoxia-inducible apoptotic stimulator in endothelial cells. J Biol Chem 284, 24436-24443.
22. Jones DP (2006). Redifining oxidative stress. Antioxid Redox Signal 8, 1865-1879.
23. Kunz GA, Liang G, Cuculi F, Gregg D, Vata KC, Shaw LK et al (2006). Circulating endothelial progenitor cells predict coronary artery disease severity. Am Heart J 152, 190-195.
24. Leone AM, Valgimigli M, Giannico MB, Zaccone V, Perfetti M, D'Amario D et al (2009). From bone marrow to the arterial wall: the ongoing tale of endothelial progenitor cells. Eur Heart J 30, 890-899.
25. Magalhães J, Ascensão A, Viscor G, Soares J, Oliveira J, Marques F & Duarte J (2004). Oxidative stress in humans during and after 4 h of hypoxia at a simulated altitude of 5500 m. Aviat Space Environ Med 75, 16-22.
26. Mancuso P, Colleoni M, Calleri A, Orlando L, Maisonneuve P, Pruneri G et al (2006). Circulating endothelial-cell kinetics and viability predict survival in breast cancer patients receiving metronomic chemotherapy. Blood 108, 452-459.
27. Mancuso P, Peccatori F, Rocca A, Calleri A, Antoniotti P, Rabascio C et al (2008). Circulating endothelial cell number and viability are reduced by exposure to high altitude. Endothelium 15, 53-58.
28. Martinelli M, Winterhalder R, Cerretelli P, Howald H & Hoppeler H (1990). Muscle lipofuscin content and satellite cell volume is increased after high altitude exposure in humans. Experientia 46, 672-676.
29. Massa M, Rosti V, Ferrario M, Campanelli R, Ramajoli I, Rosso R et al (2005). Increased circulating hematopoietic and endothelial progenitor cells in the early phase of acute myocardial infarction. Blood 105, 199-206.
30. Mobius-Winkler S, Hilberg T, Menzel K, Golla E, Burman A, Schuler G & Adams V (2009). Time-dependent mobilization of circulating progenitor cells during strenuous exercise in healthy individuals. J Appl Physiol 107, 1943-1950.
31. O'Neil TJ, Wamhoff BR, Owens GK & Skalak TC (2005). Mobilization of bone marrow-derived cells enhances the angiogenic response to hypoxia without transdifferentiation into endothelial cells. Circ Res 97, 1027-1035.
32. Palange P, Testa U, Huertas A, Calabrò L, Antonucci R, Petrucci E et al (2006). Circulating haemopoietic and endothelial progenitor cells are decreased in COPD. Eur Resp J 27, 529-541.
33. Peichev M, Naiyer AJ, Pereira D, Zhu Z, Lane WJ, Williams M et al (2000). Expression of VEGFR-2 and AC133 by circulating human CD34+ cells identifies a population of functional endothelial precursors. Blood 95, 952-958.
34. Peled A, Grabovsky V, Habler L, Sandbank J, Arenzana-Seisdedos F, Petit I et al (1999). The chemokine SDF-1 stimulates integrin-mediated arrest of CD34+ cells on vascular endothelium under shear flow. J Clin Invest 104, 1199-1211.
35. Pialoux V, Mounier R, Brown AD, Steinback CD, Rawling JM & Poulin MJ (2009). Relationship between oxidative stress and HIF-1α mRNA during sustained hypoxia in humans. Free Radic Biol Med 46, 321-326.
36. Sandau KB, Fandrey J & Brune B (2001). Accumulation of HIF-1α under the influence of nitric oxide. Blood 97, 1009-1015.
37. Sandri M, Adams V, Gielen S, Linke A, Lenk K, Kränkel N et al (2005). Effects of exercise and ischemia on mobilization and functional activation of blood-derived progenitor cells in patients with ischemic syndromes: results of 3 randomized studies. Circulation 111, 3391-3399.
38. Schatteman GC, Hanlon HD, Jiao C, Dodds SG & Christy BA (2000). Blood-derived angioblasts accelerate blood-flow restoration in diabetic mice. J Clin Invest 106, 571-578.
39. Schmidt-Lucke C, Rossig L, Fichtlscherer S, Vasa M, Britten M, Kamper U et al (2005). Reduced number of circulating endothelial progenitor cells predicts future cardiovascular events: proof of concept for the clinical importance of endogenous vascular repair. Circulation 111, 2981-2987.
40. Simon HU, Haj-Yehia A & Levi-Schaffer F (2000). Role of reactive oxygen species (ROS) in apoptosis induction. Apoptosis 5, 415-418.
41. Sirker AA, Astroulakis ZMJ & Hill JM (2009). Vascular progenitor cells and translational research: the role of endothelial and smooth muscle progenitor cells in endogenous arterial remodelling in the adult. Clin Sci 116, 283-299.
42. Taddeo A, Presicce P, Brambilla L, Bellinvia M, Villa ML & Della Bella S (2008). Circulating endothelial progenitor cells are increased in patients with classic Kaposi's sarcoma. J Invest Dermatol 128, 2125-2128.
43. Takagi Y, Hashimoto N, Phan SH, Imaizumi K, Matsuo M, Nakashima H et al (2009). Erythromycin-induced CXCR4 expression on microvascular endothelial cells. Am J Physiol Lung Cell Mol Physiol 297, L420-L431.
44. Theiss HD, Adam M, Greie S, Schobersberger W, Humpeler E & Franz WM (2008). Increased levels of circulating progenitor cells after 1-week sojourn at moderate altitude. Respir Physiol Neurobiol 160, 232-238.
45. Urbich C & Dimmeler S (2004). Endothelial progenitor cells: characterization and role in vascular biology. Circ Res 95, 343-353.
46. Valgimigli M, Rigolin GM, Fucili A, Porta MD, Soukhomovskaia O, Malagutti P et al (2004). CD34+ and endothelial progenitor cells in patients with various degrees of congestive heart failure. Circulation 110, 1209-1212.
47. Vasa M, Fichtlscherer S, Aicher A, Adler K, Urbich C, Martin H et al (2001). Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res 89, e1-e7.
48. Verma S, Kuliszewski MA, Li SH, Szmitko PE, Zucco L, Wang CH et al (2004). C-reactive protein attenuates endothelial progenitor cell survival, differentiation, and function: further evidence of a mechanistic link between C-reactive protein and cardiovascular disease. Circulation 109, 2058-2067.
49. Viscor G, Javierre C, Pagès T, Ventura JL, Ricart A, Martin-Henao G et al (2009). Combined intermittent hypoxia and surface muscle electrostimulation as a method to increase peripheral blood progenitor cell concentration. J Transl Med 7, 91.
50. Wassmann S, Werner N, Czech T & Nickenig G (2006). Improvement of endothelial function by systemic transfusion of vascular progenitor cells. Circ Res 99, e74-e83.
51. Werner N, Kosiol S, Schiegl T, Ahlers P, Walenta K, Link A et al (2005). Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Med 353, 999-1007.
52. Xiao Q, Ye S, Oberhollenzer F, Mayr A, Jahangiri M, Willeit J et al (2008). SDF1 gene variation is associated with circulating SDF1α level and endothelial progenitor cell number - the Bruneck Study. PloS ONE 3, e4061.
53. Zentilin L, Tafuro S, Zacchigna S, Arsic N, Pattarini L, Sinigaglia M & Giacca M (2006). Bone marrow mononuclear cells are recruited to the sites of VEGF-induced neovascularization but are not incorporated into the newly formed vessels. Blood 107, 3546-3554.
54. Zhang Y, Foudi A, Geay J-F, Berthebaud M, Buet D, Jarrier P et al (2004). Intracellular localization and constitutive endocytosis of CXCR4 in human CD34+ hematopoietic progenitor cells. Stem Cells 22, 1015-1029.
55. Zuo L & Clanton TL (2005). Reactive oxygen species formation in the transition to hypoxia in skeletal muscle. Am J Physiol Cell Physiol 289, C207-C216.